82
Views
9
CrossRef citations to date
0
Altmetric
REDUCTION OF RADIATION-INDUCED CARCINOGENESIS IN RATS

Anticarcinogenic activity of alpha-difluoromethylornithine, ginseng, eleutherococcus, and leuzea on radiation-induced carcinogenesis in female rats

, , , &
Pages 1191-1200 | Received 19 Dec 2013, Accepted 04 Jun 2014, Published online: 10 Jun 2014
 

Abstract

Purpose: To carry out a comparative study of inhibition of radiation carcinogenesis using alpha-difluoromethylornithine (DFMO), tinctures of ginseng, eleutherococcus and leuzea in female rats.

Materials and methods: Locally bred female LIO-strain rats were subjected to a single whole body γ-irradiation dose of 4 Gy at 12 weeks of age. Modifying drugs were given with drinking water from the 10th day after irradiation until the end of the experiment (for 16 months).

Results: Irradiated rats developed tumors 70.0–79.6% (malignant tumors: 43.7–45.0%) with a multiplicity of 1.48–1.75 (malignant: 0.5–0.58), while in unirradiated animals the incidence of all/malignant tumors was 21.9%/7.7% with multiplicity of 0.22/0.08. In exposed rats tumors most often developed in the mammary gland – 57.3%, reproductive and endocrine organs – 27.2%, and other localizations – 29.1%. All drugs, except leuzea, significantly reduced incidence and multiplicity of tumors, overall or at some localizations in irradiated rats. Highest, and practically equal inhibition, was shown by ginseng and DFMO, while eleutherococcus was clearly inferior. Ginseng reduced overall tumor incidence and multiplicity by 1.5 and 2.4 times, malignant tumor incidence and multiplicity – by 2.5 and 2.9 times, respectively.

Conclusions: The ginseng extract is the most promising radiation carcinogenesis inhibitor tested.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

The work was supported partially by grant from the fund ‘Technologies. Introduction. Science’, Saint Petersburg, Russia, project No. 16939/6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.